{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:30:04Z","timestamp":1791462604054,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ymgme.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T21:42:11Z","timestamp":1368913331000},"page":"312-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Stbd1 is highly elevated in skeletal muscle of Pompe disease mice but suppression of its expression does not affect lysosomal glycogen accumulation"],"prefix":"10.1016","volume":"109","author":[{"given":"Haiqing","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri B.","family":"Fredrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuti","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2013.05.004_bb0005","series-title":"Scriver's Online Metabolic & Molecular Bases of Inherited Disease","article-title":"Glycogen storage diseases","author":"Chen","year":"2009"},{"key":"10.1016\/j.ymgme.2013.05.004_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0015","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/GIM.0b013e31819d0996","article-title":"Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease","volume":"11","author":"Nicolino","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"Pt 3","key":"10.1016\/j.ymgme.2013.05.004_bb0030","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/bj3350549","article-title":"Molecular cloning and functional expression of a novel human gene encoding two 41\u201343kDa skeletal muscle internal membrane proteins","volume":"335","author":"Bouju","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0035","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/bioinformatics\/18.11.1534","article-title":"A motif of a microbial starch-binding domain found in human genethonin","volume":"18","author":"Janecek","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymgme.2013.05.004_bb0040","doi-asserted-by":"crossref","first-page":"34960","DOI":"10.1074\/jbc.M110.150839","article-title":"Starch binding domain-containing protein 1\/genethonin 1 is a novel participant in glycogen metabolism","volume":"285","author":"Jiang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0045","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/pmic.200900628","article-title":"Analysis of hepatic glycogen-associated proteins","volume":"10","author":"Stapleton","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.ymgme.2013.05.004_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1525-0016(02)00055-2","article-title":"Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector","volume":"7","author":"Sun","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0055","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/mt.2008.133","article-title":"Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy","volume":"16","author":"Sun","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0060","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1089\/10430349950017563","article-title":"Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system","volume":"10","author":"Hermens","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0065","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","article-title":"Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0075","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1242\/dmm.009712","article-title":"Characterization of a canine model of glycogen storage disease type IIIa","volume":"5","author":"Yi","year":"2012","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0080","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1093\/hmg\/ddn292","article-title":"Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease","volume":"17","author":"Raben","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2013.05.004_bb0085","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4161\/auto.6.8.13378","article-title":"Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder \u2014 murine Pompe disease","volume":"6","author":"Raben","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.ymgme.2013.05.004_bb0090","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","article-title":"Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II","volume":"12","author":"Franco","year":"2005","journal-title":"Mol. Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T23:25:27Z","timestamp":1539645927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719213001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1096719213001704"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.05.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stbd1 is highly elevated in skeletal muscle of Pompe disease mice but suppression of its expression does not affect lysosomal glycogen accumulation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}